SCHEMBL9367686

SCHEMBL9367686

C1=C(c2cccs2)CCC(N2CCN(c3ccccn3)CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9367787 0.83
SCHEMBL2021022 0.82
SCHEMBL9367241 0.82 DRD2 (0.45)
SCHEMBL9367611 0.81
SCHEMBL9368439 0.80 DRD2 (0.54)
SCHEMBL19823058 0.79 HTR1A (0.46)
SCHEMBL9367638 0.78
SCHEMBL9872091 0.73 HTR1A (0.49)
SCHEMBL9200836 0.72 LMNA (0.53)
SCHEMBL9367385 0.70 KDM4E (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0431579-B1 Substituted cyclohexenes as central nervous system agents WARNER LAMBERT CO (US) 1994-07-27 EP claimed
EP-0431579-A2 Substituted cyclohexenes as central nervous system agents WARNER-LAMBERT COMPANY (US) 1991-06-12 EP claimed
EP-0431579-B1 Substituted cyclohexenes as central nervous system agents WARNER LAMBERT CO (US) 1994-07-27 EP disclosed
EP-0431579-A2 Substituted cyclohexenes as central nervous system agents WARNER-LAMBERT COMPANY (US) 1991-06-12 EP disclosed
US-4975445-A Antidepressants WARNER-LAMBERT COMPANY (US) 1990-12-04 US disclosed